Article

Japan Offers Potential Ebola Treatment as Outbreak Continues

Author(s):

Efforts to combat the ongoing Ebola outbreak in West Africa have gone global as Japan recently announced efforts to provide medical assistance to the cause.

Efforts to combat the ongoing Ebola outbreak in West Africa have gone global as Japan recently announced efforts to provide medical assistance to the cause.

A story from Reuters said a drug known as T-705 (faxipiravir) has gained some attention as a possible treatment for Ebola. While it has not been approved for treatment of the virus, and has been used mostly as an influenza drug, Chief Cabinet Secretary Yoshihide Suga said it could be an option in this medical crisis.

“I am informed that medical professionals could make a request for T-705 in an emergency even before a decision (on approval) by the WHO. In that case, we would like to respond under certain criteria,” he told Reuters.

The news from Japan comes amid reports from CNN and other news outlets that a new strain of Ebola has been confirmed in the Democratic Republic of Congo.

The World Health Organization (WHO) recently reported that one problem facing recovery efforts in Africa is the fact that many people treating patients have become patients themselves. The most recent data shows that 240 health care workers have been infected in Guinea, Liberia, Nigeria, and Sierra Leone, with more than half the cases ending in death.

“Several factors help explain the high proportion of infected medical staff,” a press release from the WHO said. “These factors include shortages of personal protective equipment or its improper use, far too few medical staff for such a large outbreak, and the compassion that causes medical staff to work in isolation wards far beyond the number of hours recommended as safe.”

Related Videos
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
© 2024 MJH Life Sciences

All rights reserved.